en · de · es · pt
lab-handbook.peptides5388.com › Faq › Background And Mechanism Of Sr9009 — Questions and Answers

Background And Mechanism Of Sr9009 — Questions and Answers

By Editorial Desk · published 2025-08-15 · last reviewed 2025-10-05 · Faq

REV-ERB agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2025-10-05. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Mechanism of SR9009

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.

SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.

Analytical and Handling Considerations

SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.

For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall-molecule ligand; not a hormone or peptide
Molecular formulaC20H24ClN3O4SReported for the free base
CAS Registry Number1379686-30-2Unique chemical identifier
Common synonymsSR9009; stenabolicStenabolic is informal and not an official name
Reported targetsREV-ERBα and REV-ERBβNuclear receptors linked to circadian and metabolic regulation

Analytical Detection and Laboratory Handling

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

Related pages on this site

SR9009 Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Notes from published material

External (interface) pressure applied over an area of the body, especially over the bony prominences can result in obstruction of the blood capillaries, which deprives tissues of oxygen and nutrients, causing ischemia (deficiency of blood in a particular area), hypoxia (inadequate amount of oxygen available to the cells), edema, inflammation, and, finally, necrosis and ulcer formation. Ulcers due to external pressure occur over the sacrum and coccyx, followed by the trochanter and the calcaneus (heel). In healthy individuals, ulcers caused by external pressure do not occur when the body is stationary, such as during sleep, as involuntary movements of the body frequently occur, allowing for repositioning and the relief of pressure. Friction is damaging to the superficial blood vessels directly under the skin. It occurs when two surfaces rub against each other. The skin over the elbows can be injured due to friction. The back can also be injured when patients are pulled or slid over bed sheets while being moved up in bed or transferred onto a stretcher. Shearing is a separation of the skin from underlying tissues. When a patient is partially sitting up in bed, skin may stick to the sheet, making the skin susceptible to shearing in case underlying tissues move downward with the body toward the foot of the bed. This may also be possible on a patient who slides down while sitting in a chair. Moisture is also a common pressure ulcer culprit. Sweat, urine, feces, or excessive wound drainage can further exacerbate the damage done by pressure, friction, and shear.

=== Industrial === Chitin is used in many industrial processes. Examples of the potential uses of chemically modified chitin in food processing include the formation of edible films and as an additive to thicken and stabilize foods and food emulsions. Processes to size and strengthen paper employ chitin and chitosan.

In England, an estimated 2,189,300 people were thought to have tested positive for COVID-19. 14 January Four women and two children are injured in a drive-by mass shooting close to a Catholic church in Euston Road, Euston, Central London. A 22-year-old man is arrested two days later on suspicion of attempted murder. Amid recent heavy rain, more than 100 flood warnings by the Environment Agency remain in place across the country, with hundreds of homes damaged and many left without power. Rishi Sunak confirms that the UK will send 14 Challenger 2 tanks to Ukraine to boost its war effort. 16 January Serving Metropolitan Police officer David Carrick admits over 40 offences including more than 20 rapes against 12 women over two decades. The National Education Union announces that teachers in England and Wales will strike on seven dates during February and March after members voted in favour of strike action. National strikes will be held on 1 and 15 February, and 15 March, as well as four days of regional strikes. The UK government announces it will block the Gender Recognition Reform (Scotland) Bill, the first time that the UK government has used powers to block a Scottish law. UK ministers say the draft law would "conflict with equality protections applying across Great Britain". The Royal College of Nursing announces a further two nurses' strikes for 6 and 7 February, described as the biggest so far. MPs vote 309–249 in favour of the Strikes (Minimum Service Levels) Bill 2023, which now moves to the committee stage.

=== Structure === Tetrahymanol is a pentacyclic triterpenoid molecule. The triterpenoids are a class of molecules found in both bacteria and eukaryotes, which largely make hopanols and sterols, respectively. The structures of these three classes of molecules are shown below. Cholesterol and diploptene are used as model sterol and hopanol structures, respectively. While diploptene and tetrahymanol broadly have similar structures, the fifth ring on tetrahymanol is a cyclohexane rather than a cyclopentane. All three of these molecular classes have structures that lend themselves to membrane rigidity and other, still unknown, physiological functions. The similarity of tetrahymanol to the other classes of triterpenoid molecules allows it to substitute for hopanols and sterols in cell membranes. The tetrahymanol structure can have multiple stereoisomers. Its chiral methyl and hydrogen substituents can switch enantiomers during diagenesis, giving the molecule different properties with each isomer. When gammacerane, the diagenetic product of tetrahymanol, is analyzed, its isomers can be separated and provide information about the origin and thermal maturity of the sample.

Sources: en.wikipedia.org

Background from the literature

Although both acids cause a Pd+ orange to orange-red medulla reaction, a potassium (K) spot test can separate the species: the medulla of P. perlatum turns yellow (K+ yellow), whereas in P. stuppeum, the yellow colour turns red (K+ yellow turning red). Parmotrema perlatum can be distinguished from other sorediate and marginally ciliate species like P. arnoldii and P. robustum by the presence of the stictic acid chemosyndrome. Also, the medulla of P. arnoldii fluoresces strongly when lit with an ultraviolet lamp. Parmotrema perlatum is similar to P. crinitum due to both species having a brown to tan, erhizinate marginal zone and the presence of the stictic acid chemosyndrome in the medulla. However, P. crinitum can be distinguished by its isidiate upper surface. Another potential lookalike, P. margaritatum, is distinguished from P. perlatum by the K+ (red) reaction of its medulla. Cetrelia cetrarioides has been documented as a lookalike, presumably because of the cilia on its thallus margin, and the presence of atranorin and the stictic acid chemosyndrome.

=== Warehousing and distribution === Warehousing and distribution are major logistics segments, and are among the fastest-growing logistics services in South Africa. Numerous developers have constructed large (30,000 sqm+) warehouse facilities along the N3 and N1 corridors, to facilitate the storage and distribution of consumer goods, including those from e-commerce companies. These warehouses support a retail sector that in 2024 was worth approximately R1.4 trillion. The presence of e-commerce companies such as Takealot, Amazon, AliExpress, Temu, and Shein continues to grow in South Africa, and these companies make extensive use of warehousing. South Africa's food storage capacity as a proportion of production is high, and only slightly behind China's, despite having a population that is 21 times smaller. Warehousing in South Africa is shifting from passive storage to technology-intensive logistics operations. Automation, inventory optimization, and e-commerce fulfilment are driving value-added services beyond traditional storage. Cold chain storage in South Africa is growing, supported by the food and pharmaceutical industries. South Africa's cold chain storage sector is the largest and most mature in Africa. As of 2025, prime rent for warehousing averaged around R100 per sqm, and the average yield (return) was 8.25%. Warehouses tend to be concentrated in and around South Africa's largest cities - most notably Durban, Johannesburg, and Cape Town. The primary use varies between cities.

=== Dehydrated and freeze-dried === Dehydrated or freeze-dried meals come in raw and cooked forms. Products are usually air-dried or frozen, then dehydrated (freeze-dried) to reduce moisture to the level where bacterial growths are inhibited. The appearance is very similar to dry dog pellets. The typical feeding methods include adding warm water before serving. There is some concern of nutrients, such as vitamins, being lost during the dehydration process. Specialty small batches sold through specialty or online stores generally consist of some form of cooked meat, ground bone, pureed vegetables, taurine supplements, and other multivitamin supplements. Some pet owners use human vitamin supplements, and others use vitamin supplements specifically engineered for dogs.

Sources: en.wikipedia.org

Reference notes

He began his campaign by defeating home favourite Matteo Berrettini who retired with an injury. On his way to the title he defeated the top two seeds Djokovic and Medvedev in the semifinals and finals respectively. Due to this win, he became the only player active to have won multiple ATP Finals titles (2) other than Djokovic and Roger Federer, with 7 and 6, respectively.

In the initial phase of Germany's invasion of the Soviet Union, Cossack émigrés were initially barred from political activity or travelling into the occupied Eastern territories. Hitler had no intention of entertaining the political aspirations of the Cossacks, or any minority group, in the USSR. As a result, collaboration between Cossacks and the Wehrmacht began in ad hoc manner through localized agreements between German field commanders and Cossack defectors from the Red Army. Hitler did not officially sanction the recruitment of Cossacks and lift the restrictions imposed on émigrés until the second year of the Nazi-Soviet conflict. During their brief occupation of the North Caucasus region, the Germans actively recruited Cossacks into detachments and local self-defense militias. The Germans even experimented with a self-governing district of Cossack communities in the Kuban region. When the Wehrmacht withdrew from the North Caucasus region in early 1943, tens of thousands of Cossacks retreated with them, either out of conviction or to avoid Soviet reprisals. In 1943, the Germans formed the 1st Cossack Cavalry Division, under the command of General Helmuth von Pannwitz. While its ranks mostly comprised deserters from the Red Army, many of its officers and NCOs were Cossack émigrés who had received training at one of the cadet schools established by the White Army in Yugoslavia. The division was deployed to occupied Croatia to fight Tito's Partisans. There, its performance was generally effective, although at times brutal.

The most stable and dense form of selenium is gray and has a chiral hexagonal crystal lattice (space group 152 or 154 depending on the chirality) consisting of helical polymeric chains, where the Se–Se distance is 237.3 pm and Se–Se–Se angle is 103.1°. The minimum distance between chains is 343.6 pm. Gray selenium is formed by mild heating of other allotropes, by slow cooling of molten selenium, or by condensing selenium vapor just below the melting point. Whereas other selenium forms are insulators, gray selenium is a semiconductor showing appreciable photoconductivity. Unlike the other allotropes, it is insoluble in CSs. It resists oxidation by air and is not attacked by nonoxidizing acids. With strong reducing agents, it forms polyselenides. Selenium does not exhibit the changes in viscosity that sulfur undergoes when gradually heated.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.

Is SR9009 approved for human use?

No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.

How does SR9009 differ from natural REV-ERB ligands?

Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.

How is SR9009 detected in laboratory samples?

Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.

Network